EGFR Resisters Research Summit
@EGFRSummit
Summit: Nov 6–8, 2025 • Rosemont, Il Educational Partners: @egfrresisters @CEC_onc Abstract Submission: August 8th Submit Your Abstract Below
Are you a Young Investigator working on EGFR-mutant lung cancer? ✨ Finalists present live, receive coaching, and connect with top experts and patient advocates. Apply by Aug 8 - ceconcepts.com/egfr-summit #EGFRSummit #LungCancerResearch
🧬 Got unpublished research in EGFRm lung cancer? Apply to the #EGFRSummit — finalists get a travel scholarship, expert mentorship, and a national stage to present their work. Deadline: Aug 8 Submit Abstract: ceconcepts.com/egfr-summit #LungCancer #LungCancerResearch #EGFR

We would like to inform you that your post has been published on OncoDaily. Thank you for sharing. oncodaily.com/blog/jill-feld…
🔍 We’re looking for the next wave of leaders in EGFR-mutated NSCLC! Submit your abstract or career statement and join us Nov 6–8 in Chicago. 🗓 Deadline: Aug 8 Register here: ceconcepts.com/egfr-summit @ZPiotrowskaMD @jillfeldman4 #LungCancer #LungCancerResearch #EGFR #EGFRSummit
Calling all #thoracic #oncology leaders! We’re inviting early career investigators to submit an abstract for a chance to join us at the 7th Annual EGFR Resisters Research Summit @EGFRSummit, (Nov 6–8 in Chicago). Please share this opportunity with your fellows, postdocs, or…
🚨 Abstract call now open! Are you a fellow or junior faculty researching EGFR-mutant NSCLC? Submit your work to the #EGFRSummit for a chance to present, network, and grow. Deadline: Aug 8 Submit Abstract: ceconcepts.com/egfr-summit @ZPiotrowskaMD @jillfeldman4 #LungCancer

🧬 Got unpublished research in EGFRm lung cancer? Apply to the #EGFRSummit — finalists get a travel scholarship, expert mentorship, and a national stage to present their work. Deadline: Aug 8 Submit Abstract: ceconcepts.com/egfr-summit #LungCancer #LungCancerResearch #EGFR

🔍 We’re looking for the next wave of leaders in EGFR-mutated NSCLC! Submit your abstract or career statement and join us Nov 6–8 in Chicago. 🗓 Deadline: Aug 8 Register here: ceconcepts.com/egfr-summit @ZPiotrowskaMD @jillfeldman4 #LungCancer #LungCancerResearch #EGFR #EGFRSummit
Are you a Young Investigator working on EGFR-mutant lung cancer? ✨ Finalists present live, receive coaching, and connect with top experts and patient advocates. Apply by Aug 8 - ceconcepts.com/egfr-summit #EGFRSummit #LungCancerResearch
🚨 Abstract call now open! Are you a fellow or junior faculty researching EGFR-mutant NSCLC? Submit your work to the #EGFRSummit for a chance to present, network, and grow. Deadline: Aug 8 Submit Abstract: ceconcepts.com/egfr-summit @ZPiotrowskaMD @jillfeldman4 #LungCancer

very interesting we are finding more options for patients with uncommon mutations including ami+laz @EGFRResisters @EgfrUk @EGFRSummit @egfr #lungcancer #lcsm
Uncommon EGFR mutations in NSCLC often fly under the radar. This is one slide showing the first-line data for uncommon EGFR mutations — from 4 trials - ACHILLES, UNICORN, KCSG-lu15-09 , and CHRYSALIS-2 ( cohort C ) #oncotwitter #uncomonEGFR #LCSM @OncoAlert @OncBrothers
❤️ Thank you, Diane.
The team at CE Concepts honors the memory and incredible work of Diane Legg, EGFR-positive lung cancer patient advocate. Her dedication knew no bounds. We are proud to have worked with Diane on our annual EGFR Young Investigator Forum (@EGFRSummit), where she supported early…
i agree but you can see that tremendous unmet need we have now the option will be docetaxe at least this is less toxic and adds one more option for our patients to prolong survival #lungcancer #lcsm @EGFRResisters @EgfrUk @EGFRSummit @EGFRmNSCLC
Hard to get excited about 5 month PFS. We should be aiming much higher.
Opioid Early Career Scholar Program An intensive multi-day opioid REMS initiative in Pain Management Register Today Early Bird Deadline: February 14th March 15-16, 2025 Wyndham Garden Lake Buena Vista Buena Vista, FL @cmeoutfitters #health #wellness
Must-attend for oncologists and urologists! Excited to expand my knowledge on ADCs and adverse events. #CME #MedEd
Very good news for EGFR-mutated NSCLC patients. @EGFRResisters @EGFRSummit @AEACaP #LCSM
European Commission Approves Lazertinib Plus Amivantamab in First-Line EGFR-Mutated NSCLC #lcsm #oncology onclive.com/view/european-…
This has been a good year with more options for our patients @EGFRResisters @EgfrUk @EGFRSummit @ALKpositiveINT @ALKPositiveinc @metcrusaders @METCrusaders1 #lungcancer #lcsm
2024 approvals: Summary of 14 new drugs/indications in #LungCancer by @US_FDA 1. #Tepotinib 2. #Osimertinib x2 3. #Alectinib 4. #Tarlatamab 5. #Zenocutuzumab 6. #Durvalumab x2 7. #Amivantamab x2 8. #Nivolumab 9. #Ensartinib #lcsm #OncTwitter #MedTwitter
Congratulations to Christina Mercado Jimenez of the @MeilerLab!
Honorable Mention: Christina M. Jimenez, BS of @VanderbiltU @VanderbiltChem @VanderbiltCSB Evaluating the Structural Basis of NSCLC Mutant Dimerization within the Trans- and Juxtamembrane Region of EGFR and HER2 #EGFR #MedEd #MedTwitter #MedX #EGFRSummit
Congratulations to this year’s award winners at #EGFR24! #EGFR #MedEd #MedTwitter #MedX #EGFRSummit #LCSM @jillfeldman4 @ZPiotrowskaMD @StephenVLiu @HelenaYu923 @maryjofidlerMD @egfrresisters @CEC_onc @CE_Concepts
